Repligen
RGEN
446 hedge funds and large institutions have $9.06B invested in Repligen in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 154 increasing their positions, 159 reducing their positions, and 45 closing their positions.
42% more call options, than puts
Call options by funds: $48.5M | Put options by funds: $34.2M
20% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 45
1.1% more ownership
Funds ownership: 96.35% → 97.46% (+1.1%)
1% more funds holding
Funds holding: 442 → 446 (+4)
0% more capital invested
Capital invested by funds: $9.02B → $9.06B (+$39.9M)
3% less repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 159
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| 1 |
BlackRock
New York
|
+$204M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$181M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$118M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$71M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$49.5M |
Top Sellers
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$263M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$234M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$36.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$32.3M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$30.1M |
RGEN Hedge Fund Activity: Q1 2023 in Review
446 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2023, worth a combined $9.06B — up 0.44% from $9.02B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new RGEN positions and 45 closed out — a net gain of 9 holders — while 154 added to existing stakes and 159 trimmed.
The largest buyer was BlackRock, adding an estimated $204M. The largest seller was WCM Investment Management, cutting an estimated $263M.
- 446 institutional investors held Repligen (RGEN) as of Q1 2023, up from 442 in Q4 2022.
- Funds reported $9.06B of Repligen stock for Q1 2023, up 0.44% quarter-over-quarter.
- 54 funds opened new Repligen positions in Q1 2023 and 45 closed out, a net change of +9 holders.
- The largest Repligen buyer in Q1 2023 was BlackRock, an estimated $204M added.
- The largest Repligen seller in Q1 2023 was WCM Investment Management, an estimated $263M sold.
Based on aggregated 13F filings for Q1 2023.